RE: Priority Review21 Dec 2019 17:25
A great post Jatw, it has been nice to exchange views with you and others on this BB this year. I have been an Investor in Chi-Med since 2008 and have really enjoyed seeing the Company grow and deliver to patients and Investors. The best is yet to come of course. I would also encourage those that can attend the AGM. I hope one day we get that HK IPO and the AGM's are in HK, any excuse to return to the place I know quite well is good with me!
Savolitinib approval in China for Exon 14 del will be wonderful as will the first ever global approval, targeted for Savo combination with Tagrisso
Here's to a wonderful 2020!